Form 10-K405 - Annual report [Sections 13 and 15(d), S-K Item 405]:
SEC Accession No. 0000950135-99-003354
Filing Date
1999-06-29
Accepted
1999-06-29 00:00:00
Documents
15
Period of Report
1999-03-31

Document Format Files

Seq Description Document Type Size
1 ALKERMES, INC. 10-K405 289413
2 1999 PREFERRED STOCK TERMS EX-3.1(F) 53326
3 NON-VOTING COMMON STOCK TERMS EX-3.1(G) 9315
4 BY-LAWS EX-3.2 30682
5 SPECIMEN CERIFICATE, 1999 PREFERRED STOCK EX-4.3 2901
6 SPECIMEN CERTIFICATE, NON-VOTING COMMON SHARES EX-4.4 2829
7 1998 EQUITY INCENTIVE PLAN EX-10.6 34592
8 1999 STOCK OPTION PLAN EX-10.7 28511
9 LICENSE AGREEMENT EX-10.18 89907
10 DISCONTINUATION AGREEMENT EX-10.19 6811
11 PATENT LICENSE AGREEMENT EX-10.25 108049
12 INCENTIVE LOAN PROGRAM EX-10.42 2954
13 SUBSIDIARIES EX-21 1019
14 DELOITTE & TOUCHE CONSENT EX-23 609
15 FINANCIAL DATA SCHEDULE EX-27 2267
  Complete submission text file 0000950135-99-003354.txt   665925
Mailing Address
Business Address 64 SIDNEY ST CAMBRIDGE MA 02139-4136 6174940171
ALKERMES INC (Filer) CIK: 0000874663 (see all company filings)

EIN.: 232472830 | State of Incorp.: PA | Fiscal Year End: 0331
Type: 10-K405 | Act: 34 | File No.: 001-14131 | Film No.: 99655224
SIC: 2834 Pharmaceutical Preparations